OxRML/AgentSLR huggingface dataset:
Pathogen: Lassa mammarenavirus
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Lower bound: 1.05
Upper bound: 1.62
Bounds: 1.05 - 1.62
Epidemic phase: Endemic
Reproduction number method: Growth rate
Reproduction number pathway: Other
Disaggregated by: Method, Other, Region, Time
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Nigeria
Location: Edo, Ondo, Ebonyi, Bauchi, Plateau
Study period:  Jan 01 2016 to  Mar 03 2019
Pathogen: Lassa mammarenavirus
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 67.3
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 42.4
Upper bound: 89.5
Bounds: 42.4 - 89.5
CFR/IFR numerator: 165
CFR/IFR denominator: 245
CFR/IFR method: Adjusted
Epidemic phase: Endemic
Disaggregated by: Method, Time
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 245
Country: Sierra Leone
Location: Kenema District
Study period:   2008 to   2016
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgM
Unit: Percentage (%)
Lower bound: 18
Upper bound: 22
Bounds: 18 - 22
Epidemic phase: Endemic
Disaggregated by: Disease generation, Time
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Country: Sierra Leone
Location: Kenema District
Study period:   2008 to   2016
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 5.2
Unit: Percentage (%)
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 3.6
Uncertainty upper value: 7.2
Combined uncertainty: 3.6 - 7.2 (95% CI)
CFR/IFR numerator: 34
CFR/IFR denominator: 657
Epidemic phase: Unspecified
Disaggregated by: Age, Other, Sex
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 18
Maximum age: 98
Sample size: 657
Country: Ghana
Location: Ankaakur, Ehiawenwu, Amomaso, Menkwo, Mangoase, Jirandogo, Bowena, Natorduori, Teanoba, Doniga Naveransa
Study period:  Aug 08 2010 to  Aug 08 2011
Pathogen: Lassa mammarenavirus
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 44
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 8
CFR/IFR denominator: 18
CFR/IFR method: Adjusted
Epidemic phase: Mid outbreak
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 60
Sample size: 18
Country: Benin
Location: Borgou, Donga,Collines, Alibori, Plateau, Ouémé, Atlantique, Litoral
Study period:  Dec 12 2015 to  Mar 03 2016
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 7
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 0
Uncertainty upper value: 19
Combined uncertainty: 0 - 19 (Range)
Epidemic phase: Mid outbreak
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 60
Sample size: 21
Country: Benin
Location: Borgou, Donga,Collines, Alibori, Plateau, Ouémé, Atlantique, Litoral
Study period:  Dec 12 2015 to  Mar 03 2016
Other delay start: Symptom Onset/Fever
Other delay end: Other: Sample collection/Diagnosis
Pathogen: Lassa mammarenavirus
Parameter class: Mutations
Parameter type: Mutations – substitution rate
Parameter value: 8.4
Unit: Substitutions/site/year
Value type: Unspecified
Uncertainty type: HPDI 95%
Uncertainty lower value: 7.6
Uncertainty upper value: 9.2
Combined uncertainty: 7.6 - 9.2 (HPDI 95%)
Epidemic phase: Unspecified
Sex: Unspecified
Genome site: L segment
Pathogen: Lassa mammarenavirus
Parameter class: Mutations
Parameter type: Mutations – substitution rate
Parameter value: 8.2
Unit: Substitutions/site/year
Value type: Unspecified
Uncertainty type: HPDI 95%
Uncertainty lower value: 7.2
Uncertainty upper value: 9.1
Combined uncertainty: 7.2 - 9.1 (HPDI 95%)
Epidemic phase: Unspecified
Sex: Unspecified
Genome site: S segment
Pathogen: Lassa mammarenavirus
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 31.6
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 5
CFR/IFR denominator: 16
CFR/IFR method: Adjusted
Epidemic phase: Start outbreak
Disaggregated by: Occupation, Sex
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 51
Sample size: 16
Country: Nigeria
Study period: 28 Dec 12 2017 to   2018
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Disaggregated by: Region
Risk factor: Other
Risk factor outcome: Occurrence
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 3096
Country: Nigeria
Study period:   2016 to   2019
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Disaggregated by: Region
Risk factor: Other
Risk factor outcome: Incidence
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 3096
Country: Nigeria
Study period:   2016 to   2019
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 8
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 7
Uncertainty upper value: 13
Combined uncertainty: 7 - 13 (IQR)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 8
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 7
Uncertainty upper value: 13
Combined uncertainty: 7 - 13 (IQR)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Other delay start: Symptom Onset/Fever
Other delay end: Other: Start of ribavirin treatment
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 10
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 9
Uncertainty upper value: 13
Combined uncertainty: 9 - 13 (IQR)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Other delay start: Other: Start of ribavirin treatment
Other delay end: Other: End of ribavirin treatment
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 3
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 1
Uncertainty upper value: 6
Combined uncertainty: 1 - 6 (IQR)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 61
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 11
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 10
Uncertainty upper value: 15
Combined uncertainty: 10 - 15 (IQR)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 449
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 3
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 2
Uncertainty upper value: 7
Combined uncertainty: 2 - 7 (IQR)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 92
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Other delay start: Other: Start of oxygen therapy
Other delay end: Other: End of oxygen therapy
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 8
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 7
Uncertainty upper value: 10
Combined uncertainty: 7 - 10 (IQR)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 459
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Other delay start: Other: Start of antibacterial therapy
Other delay end: Other: End of antibacterial therapy
Pathogen: Lassa mammarenavirus
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 62
CFR/IFR denominator: 510
CFR/IFR method: Adjusted
Epidemic phase: Endemic
Disaggregated by: Age, Other, Sex
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Cormobidity;Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 510
Country: Nigeria
Location: Ondo State
Study period: 5 Apr 04 2018 to 15 Mar 03 2020
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 36.1
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 9.1
Upper bound: 58.7
Bounds: 9.1 - 58.7
CFR/IFR numerator: 84
CFR/IFR denominator: 233
Epidemic phase: Endemic
Disaggregated by: Level of exposure, Occupation, Other, Region
Population group: Mixed groups
Sample type: Mixed settings
Sex: Both
Sample size: 233
Country: Nigeria
Location: Owo And Ose Lgas
Study period:  Mar 03 2018 to  Apr 04 2019
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgM
Parameter value: 8.6
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 1.9
Upper bound: 63.6
Bounds: 1.9 - 63.6
CFR/IFR numerator: 20
CFR/IFR denominator: 233
Epidemic phase: Endemic
Disaggregated by: Level of exposure, Occupation, Other, Region
Population group: Mixed groups
Sample type: Mixed settings
Sex: Both
Sample size: 233
Country: Nigeria
Location: Owo And Ose Lgas
Study period:  Mar 03 2018 to  Apr 04 2019
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgM
Parameter value: 0
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 0
CFR/IFR denominator: 12
Epidemic phase: Endemic
Population group: Other
Sample type: Hospital based
Sex: Unspecified
Sample size: 12
Country: Nigeria
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 0
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 0
CFR/IFR denominator: 12
Epidemic phase: Endemic
Population group: Other
Sample type: Hospital based
Sex: Unspecified
Sample size: 12
Country: Nigeria
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 81.7
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 58
CFR/IFR denominator: 71
Epidemic phase: Endemic
Population group: Other
Sample type: Unspecified
Sex: Both
Sample size: 71
Country: Sierra Leone
Location: Kenema District
Study period: 3 Jun 06 2019 to 28 Sep 09 2019
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
CFR/IFR numerator: 12
CFR/IFR denominator: 72
Epidemic phase: Unspecified
Population group: General population
Sample type: School based
Sex: Both
Sample size: 72
Country: Sierra Leone
Location: Freetown
Study period: 20 May 05 2019 to 24 May 05 2019
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Age;Other
Risk factor outcome: Serology
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Other
Sample type: Unspecified
Sex: Both
Sample size: 71
Country: Sierra Leone
Location: Kenema District
Study period: 3 Jun 06 2019 to 28 Sep 09 2019
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Household contact;Other
Risk factor outcome: Serology
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: School based
Sex: Both
Sample size: 72
Country: Sierra Leone
Location: Freetown
Study period: 20 May 05 2019 to 24 May 05 2019
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 7
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 5
Uncertainty upper value: 9
Combined uncertainty: 5 - 9 (IQR)
Epidemic phase: Endemic
Population group: Other
Sample type: Hospital based
Sex: Both
Sample size: 71
Country: Sierra Leone
Location: Kenema District
Study period: 3 Jun 06 2019 to 28 Sep 09 2019
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 7.5
Unit: Days
Value type: Mean
Uncertainty single value: 4.9 (Standard Deviation)
Combined uncertainty: 4.9 (Standard Deviation)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 103
Country: Liberia
Study period:  Jan 01 2019 to  Dec 12 2020
Pathogen: Lassa mammarenavirus
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 39.8
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 34.6
Upper bound: 45.1
Bounds: 34.6 - 45.1
CFR/IFR numerator: 41
CFR/IFR denominator: 103
CFR/IFR method: Unspecified
Epidemic phase: Endemic
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 103
Country: Liberia
Study period:  Jan 01 2019 to  Dec 12 2020
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 103
Country: Liberia
Study period:  Jan 01 2019 to  Dec 12 2020
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Occupation;Sex
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 103
Country: Liberia
Study period:  Jan 01 2019 to  Dec 12 2020
Pathogen: Lassa mammarenavirus
Parameter class: Growth rate
Parameter type: Growth rate (r)
Parameter value: 0.51
Unit: Per day
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 0.17
Uncertainty upper value: 1.06
Combined uncertainty: 0.17 - 1.06 (95% CI)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Nigeria
Study period: 31 Oct 10 2016 to 23 Jan 01 2017
Pathogen: Lassa mammarenavirus
Parameter class: Growth rate
Parameter type: Growth rate (r)
Parameter value: 0.43
Unit: Per day
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 0.23
Uncertainty upper value: 0.72
Combined uncertainty: 0.23 - 0.72 (95% CI)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Nigeria
Study period: 30 Oct 10 2017 to 22 Jan 01 2018
Pathogen: Lassa mammarenavirus
Parameter class: Growth rate
Parameter type: Growth rate (r)
Parameter value: 0.32
Unit: Per day
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 0.23
Uncertainty upper value: 0.64
Combined uncertainty: 0.23 - 0.64 (95% CI)
Epidemic phase: Endemic
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Nigeria
Study period: 29 Oct 10 2018 to 21 Jan 01 2019
Pathogen: Lassa mammarenavirus
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 36.7
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 11
CFR/IFR denominator: 30
CFR/IFR method: Unspecified
Epidemic phase: Endemic
Population group: Pregnant women
Sample type: Hospital based
Sex: Female
Minimum age: 16
Maximum age: 39
Sample size: 30
Country: Nigeria
Location: Irrua
Study period:   2009 to   2018
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 6
Unit: Days
Value type: Mean
Uncertainty single value: 3.1 (Standard Deviation)
Combined uncertainty: 3.1 (Standard Deviation)
Epidemic phase: Endemic
Population group: Other
Sample type: Hospital based
Sex: Female
Minimum age: 16
Maximum age: 39
Sample size: 19
Country: Nigeria
Location: Irrua
Study period:   2009 to   2018
Pathogen: Lassa mammarenavirus
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 10
Unit: Days
Value type: Mean
Uncertainty single value: 3.5 (Standard Deviation)
Combined uncertainty: 3.5 (Standard Deviation)
Epidemic phase: Endemic
Population group: Other
Sample type: Hospital based
Sex: Female
Minimum age: 24
Maximum age: 37
Sample size: 11
Country: Nigeria
Location: Irrua
Study period:   2009 to   2018
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 49.6
Unit: Percentage (%)
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 43.3
Uncertainty upper value: 55.9
Combined uncertainty: 43.3 - 55.9 (95% CI)
CFR/IFR numerator: 119
CFR/IFR denominator: 240
Epidemic phase: Endemic
Disaggregated by: Other, Time
Population group: Pregnant women
Sample type: Hospital based
Sex: Female
Minimum age: 20
Maximum age: 46
Sample size: 240
Country: Nigeria
Location: Irrua
Study period:  Feb 02 2019 to  Dec 12 2019
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Contact with animal;Other
Risk factor outcome: Serology
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Pregnant women
Sample type: Hospital based
Sex: Female
Minimum age: 20
Maximum age: 46
Sample size: 240
Country: Nigeria
Location: Irrua
Study period:  Feb 02 2019 to  Dec 12 2019
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Other
Risk factor outcome: Serology
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Pregnant women
Sample type: Hospital based
Sex: Female
Minimum age: 20
Maximum age: 46
Sample size: 240
Country: Nigeria
Location: Irrua
Study period:  Feb 02 2019 to  Dec 12 2019
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Sex
Risk factor outcome: Serology
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Other
Sample type: Community based
Sex: Both
Minimum age: 6
Maximum age: 99
Sample size: 702
Country: Guinea
Location: Basse-Guinee
Study period:   2016 to   2016
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Age;Sex
Risk factor outcome: Serology
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Mixed groups
Sample type: Community based
Sex: Both
Minimum age: 17
Maximum age: 90
Sample size: 584
Country: Guinea
Location: Guniee Forestiere
Study period:   2017 to   2018
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Other
Risk factor outcome: Serology
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Mixed groups
Sample type: Community based
Sex: Both
Minimum age: 17
Maximum age: 90
Sample size: 584
Country: Guinea
Location: Guniee Forestiere
Study period:   2017 to   2018
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 11.9
Unit: Percentage (%)
Value type: Mean
Lower bound: 0
Upper bound: 20
Bounds: 0 - 20
Uncertainty type: 95% CI
Uncertainty lower value: 9.7
Uncertainty upper value: 14.5
Combined uncertainty: 9.7 - 14.5 (95% CI)
CFR/IFR numerator: 84
CFR/IFR denominator: 702
Epidemic phase: Endemic
Disaggregated by: Region
Population group: Other
Sample type: Community based
Sex: Both
Minimum age: 6
Maximum age: 99
Sample size: 702
Country: Guinea
Location: Basse-Guinee
Study period:   2016 to   2016
Pathogen: Lassa mammarenavirus
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 59.6
Unit: Percentage (%)
Value type: Mean
Lower bound: 16.9
Upper bound: 86.84
Bounds: 16.9 - 86.84
Uncertainty type: 95% CI
Uncertainty lower value: 55.5
Uncertainty upper value: 63.5
Combined uncertainty: 55.5 - 63.5 (95% CI)
CFR/IFR numerator: 348
CFR/IFR denominator: 584
Epidemic phase: Endemic
Disaggregated by: Region
Population group: Mixed groups
Sample type: Community based
Sex: Both
Minimum age: 17
Maximum age: 90
Sample size: 584
Country: Guinea
Location: Guniee Forestiere
Study period:   2017 to   2018
Pathogen: Lassa mammarenavirus
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Endemic
Risk factor: Age;Other
Risk factor outcome: Serology
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Other
Sample type: Community based
Sex: Both
Minimum age: 6
Maximum age: 99
Sample size: 702
Country: Guinea
Location: Basse-Guinee
Study period:   2016 to   2016